Plymouth Meeting
-
LanCo Woman Among Volunteers for Clinical Trial of Inovio’s COVID-19 Vaccine
Stella Sexton, a resident of Manheim Township in Lancaster County, is among the volunteers taking part in a clinical trial to test the safety, dosage, and immune response of Inovio’s COVID-19 vaccine, writes Jeff Hawkes for the Lancaster Online. The Plymouth Meeting company is one of the very few that are already performing human testing…
-
Plymouth Meeting’s Inovio Alleges Supplier Is Withholding Critical Information on COVID-19 Vaccine
Plymouth Meeting-based Inovio Pharmaceuticals has filed a complaint with Pennsylvania state court alleging that a supplier is holding its experimental COVID-19 vaccine “hostage” by withholding some critical information needed to make it on a larger scale, write Cynthia Koons and Susan Decker for Bloomberg. Inovio claims that its contract manufacturer, GeneOne Life Science and its…
-
Bloomberg Businessweek: Plymouth Meeting’s Inovio’s COVID-19 Vaccine Among Most Promising
Drug companies and university scientists across the world are working around the clock to find a vaccine against COVID-19 and Plymouth Meeting-based Inovio Pharmaceuticals is among the companies leading the way, write Cristin Flanagan, Riley Griffin, Robert Langreth, and John Lauerman for Bloomberg Businessweek. While many experts caution that the whole process will take time,…
-
State Department of Health Enlists Plymouth Meeting Nonprofit to Help Long-Term Care Centers Battle Coronavirus
The Pennsylvania Department of Health has tapped ECRI, the Plymouth Meeting-based nonprofit, to help operators of long-term care centers battle the new strain of the coronavirus, writes John George for the Philadelphia Business Journal. ECRI is an independent research organization that focuses on protecting patients from unsafe and ineffective medical technologies and practices. It has…
-
As Share Price Dips Below $1, Owner of Willow Grove, Plymouth Meeting Malls Asking for Forgivable Federal PPP Loan to Pay Employees
PREIT, owner of Plymouth Meeting and Willow Grove malls, has applied for a “forgivable” federal Paycheck Protection Program loan to pay its employees, writes Joseph N. DiStefano for The Philadelphia Inquirer. The publicly-traded company which has seen its stock drop from a $25 high four years ago to below $1 a share furloughed over 100…
-
Bloomberg: Out of 70 Coronavirus Vaccines in Works, Inovio’s Among Three Leading Candidates
According to the World Health Organization, there are currently 70 coronavirus vaccines under development worldwide, with Inovio Pharmaceutical’s vaccine among the three leading candidates already being tested in human trials, writes Lisa Du for the Bloomberg. The other two leading candidates are an experimental vaccine from CanSino Biologics and the Beijing Institute of Biotechnology and…
-
Inovio’s Experimental COVID-19 Vaccine Given to Philadelphia Volunteers
Starting on Monday, an experimental COVID-19 vaccine created by Plymouth Meeting-based Inovio Pharmaceuticals has been administered to three Philadelphia volunteers, writes Tom Avril for The Philadelphia Inquirer. The company began working on the vaccine just ten weeks ago, after the microbe’s genetic code was published by Chinese authorities. Such an accelerated schedule in vaccine development…
-
Plymouth Meeting-Based Inovio Pharmaceuticals’ Partner Wins $11.9M DoD COVID-19 Vaccine Contract
Ology Bioservices has won an $11.9 million Department of Defense contract to work on a potential COVID-19 vaccine with Plymouth Meeting-based Inovio Pharmaceuticals, writes John George for the Philadelphia Business Journal. Under the contract, the Florida-based company will work with Inovio to support the production of its DNA vaccine, INO-4800. They are currently developing this…
-
Update: Heeding Governor’s Recommendation, Malls in King of Prussia, Plymouth Meeting and Willow Grove Close
Update: Simon Property Group, owner of the King of Prussia Mall, reversed course and closed the mall around noon Saturday. _______ In the interest of the health and safety of shoppers, store and mall employees, PREIT, the Philadelphia-based real estate trust company that owns both the Plymouth Meeting and Willow Grove Park Mall, announced Thursday…
-
MONTCO Careers – Inovio Pharmaceuticals
Plymouth Meeting’s Inovio Pharmaceuticals is engaged in the development of a new generation of vaccines, called synthetic vaccines, focused on cancers and infectious diseases. Inovio is at the forefront of the development of a vaccine for the Coronavirus. IT Applications Specialist This position ensures that all enterprise- and business-specific applications are functionally appropriate and compatible with corporate…
-
Bloomberg: Plymouth Meeting-Based Inovio in Talks to Secure Fast Delivery of Coronavirus Vaccine if Successfully Developed
Plymouth Meeting-based Inovio Pharmaceuticals is currently in talks with large drugmakers to secure prompt delivery of its coronavirus vaccine if the development is successful, writes James Paton for the Bloomberg. The biotech company aims to have a minimum of 1 million doses available by the end of this year and then rely on larger manufacturers…
-
Local Author Writes Book On How To Get Rid Of Imposter Syndrome
Ash Ambirge, a local lifestyle blogger and author, has written a book on how to get rid of imposter syndrome, writes Gina Tomaine for the Philadelphia Magazine. With “The Middle Finger Project,” which is also the name of her media company, the writer is hoping to help people stop playing small and work on pursuing…
-
Inovio Testing Unique Immunotherapy Approach To Develop Coronavirus Vaccine
Plymouth Meeting-based Inovio Pharmaceuticals has received a $9 million grant from the Coalition for Epidemic Preparedness Innovations to use its DNA medicine platform to develop a vaccine for the new strain of a coronavirus, writes Sophie Burkholder for the Philadelphia Magazine. The company believes that DNA medicine could provide a solution not just for coronavirus,…
-
Plymouth Meeting-Based Inovio Pharmaceuticals Receives Grant to Develop Vaccine for Newly Identified Coronavirus in China
Plymouth Meeting-based Inovio Pharmaceuticals has been awarded a grant of up to $9 million to rapidly develop a vaccine for the newly identified coronavirus in China, writes Stacey Burling for The Philadelphia Inquirer. Inovio’s approach to the development of vaccines is based on DNA sequencing. This is faster than traditional methods of research that need…
-
Joseph Levine & Sons to Open New Location In Blue Bell
After more than 130 years of providing funeral and burial services to the Jewish community in the Philadelphia area, Joseph Levine & Sons will now have a location in Montgomery County, writes Matt Silver for the Jewish Exponent. The fifth-generation family business is set to open a Blue Bell location in the fall next year.…


































![ForAll_Digital-Ad_Malaika_376x628[44]](https://montco.today/wp-content/uploads/sites/2/2022/06/ForAll_Digital-Ad_Malaika_376x62844.jpg)














